Select Bibliography

Filter by any of these (after searching):

Ballman, Karla

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 141 items

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Advani, Pooja P. , Ballman, Karla V. , Dockter, Travis J. ... - - J Clin Oncol - 2016

Manuscript - Primary - Long-Term-Followup - Breast - N9831

Long-term cardiac safety analysis of NCCTG (Alliance) N9831 adjuvant trastuzumab (H) trial.

Advani, Pooja Prem , Ballman, Karla V. , Dockter, Travis J. ... - ASCO - J Clin Oncol - 2014

Abstract - Primary - Long-Term-Followup - Breast - N9831

Comparative Age-Based Prospective Multi-Institutional Observations from 12,367 Patients Enrolled to American College of Surgeons Oncology Group (ACOSOG Z901101) Trials (Alliance)

Al-Refaie, Waddah B. , Decker, Paul A. , Ballman, Karla V. ... - - Ann Surg Oncol - 2019

Manuscript - Primary - Primary - Older Adult - Z901101

Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance)

Al-Refaie, Waddah B. , Decker, Paul A. , Pisters, Peter W.T. ... - SSO - Ann Surg Oncol - 2015

Abstract - Primary - Primary - Older Adult - Z901101

Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902.

Anderson, S. Keith , Miller, C. Ryan , Sarkaria, Jann N. ... - ASCO - J Clin Oncol - 2016

Abstract - Secondary - Primary - Neuro-Onc - N0874 , ABTC-0902

Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation

Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031501

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: Results of ACOSOG (American College Of Surgeons Oncology Group) Z1071 (Alliance) Substudy

Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Armer, Nathan C. ... - - Support Care Cancer - 2019

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection

Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Ostby, Pamela L. ... - - JAMA Surg - 2019

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Lymphedema results of Alliance Z1071 (American College of Surgeons Oncology Group [ACOSOG]): Self-reported symptoms and limb volume changes for breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection

Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - ILF - - 2018

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Symptoms and limb changes for breast cancer survivors treated with neoadjuvant chemotherapy: Lymphedema results of ACOSOG Z1071 (Alliance)

Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - MASCC / ISOO - Supportive Cancer Care - 2017

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

Ballman, Karla V. , Buckner, Jan C. , Brown, Paul D. ... - - Neuro-oncol - 2007

Manuscript - Primary - Primary - Neuro-Onc - N047D

Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)

Boughey, Judy C. , Ballman, Karla V. , Hunt, Kelly K. ... - - J Clin Oncol - 2015

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Identification and resection of the clipped node decreases the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla V. , Le-Petross, Huong T. ... - - Ann Surg - 2016

Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Tumor Biology and Response to Chemotherapy Impact Breast Cancer-Specific Survival in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Long-term Follow-up from ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla V. , McCall, Linda M. ... - - Ann Surg - 2017

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy–results from a prospective trial–ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla V. , Symmans, William F. ... - SABCS - Cancer Res - 2015

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Axillary Ultrasound after Neoadjuvant Chemotherapy in Patients Presenting with Node-Positive Breast Cancer (T0-T4, N1-2, M0) and its Impact on Sentinel Lymph Node Surgery in ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla , Hunt, Kelly K. , McCall, Linda M. ... - SIS - Journal of the Senologic International Society - 2014

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Tumor biology and response to chemotherapy impact breast cancer specific survival in node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection: Results from ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla , McCall, Linda , Byrd, David ... - ASA - - 2017

Abstract - Secondary - Long-Term-Followup - Breast - ACOSOG-Z1071

Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial (Alliance) ACOSOG Z1071

Boughey, Judy C. , Ballman, Karla , McCall, Linda , Kuerer, Henry ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Predictors of locoregional recurrence after neoadjuvant chemotherapy and surgery for node positive breast cancer: Results from ACOSOG Z1071 (Alliance)

Boughey, Judy C. , Ballman, Karla , McCall, Linda ... - SABCS - Cancer Res - 2017

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial

Boughey, Judy C. , McCall, Linda M. , Ballman, Karla V. ... - - Ann Surg - 2014

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Effect of the use of immediate reconstruction on the rates of bilateral mastectomy and adjuvant radiation therapy use in women with node-positive breast cancer treated with neoadjuvant chemotherapy on ACOSOG Z1071 (Alliance).

Boughey, Judy C. , McCall, Linda , Haffty, Bruce , Buchholz, Tom ... - ASCO - J Clin Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance).

Boughey, Judy C , Rosenkranz, Kari M , Ballman, Karla V ... - - J Clin Oncol - 2023

Manuscript - Primary - Primary - Breast - Z11102

Long term outcomes from intergroup NCCTG 86-72-51 (Alliance): Final report of a phase III prospective randomized trial of high dose versus low dose radiation therapy in adults with supratentorial low-grade glioma.

Breen, William G. , Anderson, S. Keith , Carrero, Xiomara W ... - SNO - Neuro-oncology - 2019

Abstract - Primary - Long-Term-Followup - Neuro-Onc - NCCTG-85-72-51

Patterns of failure after stereotactic radiosurgery versus whole brain radiotherapy for resected brain metastases: central imaging review of the NCCTG N107C/CEC.3 (Alliance) phase III clinical trial

Breen, William G. , Dooley, Katharine E. , Twohy, Erin L. ... - ASTRO - International Journal of Radiation Oncology, Biology, & Physics - 2022

Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Breen, William G , Anderson, S Keith , Carrero, Xiomara W ... - - Neuro-oncology - 2020

Manuscript - Primary - Long-Term-Followup - Neuro-Onc - NCCTG-86-72-51

NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases.

Brown, Paul D. , Asher, Anthony L. , Ballman, Karla V. ... - SNO - Neuro Oncol - 2015

Abstract - Primary - Primary - Neuro-Onc - N0574

NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases

Brown, Paul D. , Asher, Anthony L. , Ballman, Karla V. ... - ASCO - J Clin Oncol - 2015

Abstract - Primary - Primary - Neuro-Onc - N0574

N107C/CEC.3 (Alliance/NCIC): Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

Brown, Paul D. , Ballman, Karla V. , Cerhan, Jane H. ... - ASTRO - Int J Radiat Oncol Biol Phys - 2016

Abstract - Primary - Primary - Neuro-Onc - N107C

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

Brown, Paul D. , Jaeckle, Kurt , Ballman, Karla V. , Farace, Elana ... - - JAMA - 2016

Manuscript - Primary - Primary - Neuro-Onc - N0574

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Brown, Paul D , Ballman, Karla V , Cerhan, Jane H , Anderson, S Keith ... - - Lancet Oncol - 2017

Manuscript - Primary - Primary - Neuro-Onc - N107C

Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade.

Buckner, Jan C , O'Fallon, Judith R , Dinapoli, Robert P ... - - J Neurooncol - 2007

Manuscript - Primary - Primary - Neuro-Onc - NCCTG-94-72-52

Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance)

Bueno, Raphael , Richards, William G. , Harpole, David H. ... - - J Thorac Oncol - 2020

Manuscript - Primary - Meta-Analysis - Correl Sci NOS - CALGB-150807 , CALGB-140202

A randomized phase III double-blinded placebo-controlled trial of Aspirin as adjuvant therapy for Breast Cancer (Alliance A011502): The Aspirin after Breast Cancer (ABC) Trial

Chen, Wendy , Ballman, Karla V. , Winer, Eric P. , Holmes, Michelle ... - ASCO PS - Feb - J Clin Oncol - 2022

Abstract - Primary - Primary - Breast - A011502

Stereotactic Radiosurgery with or without Whole Brain Radiotherapy for Limited Brain Metastases: A Secondary Analysis of the NCCTG N0574 (Alliance) Randomized Controlled Trial

Churilla, Thomas M. , Ballman, Karla V. , Brown, Paul D. ... - - Int J Radiat Oncol Biol Phys - 2017

Manuscript - Secondary - Primary - Neuro-Onc - N0574

Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

Corless, Christopher L. , Ballman, Karla V. , Antonescu, Cristina R. ... - - J Clin Oncol - 2014

Manuscript - Secondary - Primary - GI - ACOSOG-Z9001

The Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial

Cuttino, Laurie W. , McCall, Linda , Kubicky, Charlotte ... - - Int J Radiat Oncol Biol Phys - 2022

Manuscript - Secondary - Primary - Breast - Z11102

The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Cuttino, Laurie , McCall, Linda , Kubicky, C , Ballman, Karla ... - ASTRO - International Journal of Radiation Oncology • Biology • Physics - 2019

Abstract - Secondary - Primary - Prevention - Z11102

Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy

Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - Chest - 2011

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient with N0 or N1 (Less Than Hilar) Non-Small Cell Carcinoma: Results of the ACOSOG Z0030 Trial

Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - J Thorac Cardiovasc Surg - 2011

Manuscript - Primary - Primary - Respiratory - ACOSOG-Z0030

Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial

DeMatteo, Ronald P. , Ballman, Karla V. , Antonescu, Cristina R. ... - - Ann Surg - 2013

Manuscript - Primary - Long-Term-Followup - GI - ACOSOG-Z9000

Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized, Primary Gastrointestinal Stromal Tumor (GIST)

DeMatteo, Ronald P. , Ballman, Karla V. , Antonescu, Cristina R. ... - - Lancet - 2009

Manuscript - Primary - Primary - GI - ACOSOG-Z9001

Breast lymphedema following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study

Degnim, Amy C. , Ballman, Karla V. , McCall, Linda , Hoskin, Tanya L. ... - ASBrS - The American Society of Breast Surgeons' Official Proceedings - 2020

Abstract - Secondary - Primary - Breast - Z11102

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Dueck, Amylou C. , Reinholz, Monica M. , Geiger, Xochiquetzal J. ... - - Clin Cancer Res - 2013

Manuscript - Secondary - Primary - Breast - N9831

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer

Fernandez-Martinez, Aranzazu , Pascual, Tomás , Singh, Baljit ... - - JAMA Oncol - 2023

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-40601 , PAMELA

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907

Freedman, Rachel A. , Pitcher, Brandelyn , Keating, Nancy L. ... - - Breast Cancer Res Treat - 2013

Manuscript - Secondary - Primary - Older Adult - CALGB-361002 , CALGB-49907

Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]

Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J. ... - SABCS - Cancer Res - 2015

Abstract - Secondary - Primary - Breast - CALGB-49907

The Preference to Receive Chemotherapy and Cancer-related Outcomes in Older Adults with Breast Cancer CALGB 49907 (Alliance)

Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J ... - - J Geriatr Oncol - 2018

Manuscript - Secondary-not-in-original - Primary - Older Adult - CALGB-49907

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

Galanis, Evanthia , Anderson, S Keith , Miller, C Ryan ... - - Neuro-oncology - 2018

Manuscript - Primary - Primary - Neuro-Onc - N0874

Phase II trial of vorinostat (VOR) combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (Alliance N0874/ABTC-0902)

Galanis, Evanthia , Anderson, S. Keith , Miller, C. Ryan ... - ASCO - J Clin Oncol - 2014

Abstract - Primary - Primary - Neuro-Onc - N0874

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

Giuliano, Armando E. , Ballman, Karla V. , McCall, Linda ... - - JAMA - 2017

Manuscript - Secondary - Long-Term-Followup - Breast - ACOSOG-Z0011

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: Long-Term Follow-Up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial

Giuliano, Armando E. , Ballman, Karla , McCall, Linda ... - - Ann Surg - 2016

Manuscript - Secondary - Long-Term-Followup - Breast - ACOSOG-Z0011

Association of occult metastases in sentinel lymph nodes and bone marrow with survival of women with early-stage invasive breast cancer

Giuliano, Armando E. , Hawes, Debra , Ballman, Karla V. ... - - JAMA - 2011

Manuscript - Primary - Primary - Breast - ACOSOG-Z0010

Sentinel Lymph Node Dissection With and Without Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial

Giuliano, Armando E. , Hunt, Kelly K. , Ballman, Karla. V. ... - - JAMA - 2011

Manuscript - Primary - Primary - Breast - ACOSOG-Z0011

Ten-Year Survival Results of ACOSOG Z0011 (Alliance)

Giuliano, Armando E. , Hunt, Kelly K. , Ballman, Karla. V. ... - ASCO - J Clin Oncol - 2016

Abstract - Secondary - Long-Term-Followup - Breast - ACOSOG-Z0011

Locoregional Recurrence after Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: Long-term follow-up from the American College of Surgeons Oncology Group (Alliance) Z0011 Randomized Trial

Giuliano, Armando E , McCall, Linda , Beitsch, Peter ... - ASA - - 2016

Abstract - Primary - Long-Term-Followup - Breast - ACOSOG-Z0011

Locoregional Recurrence after Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial

Giuliano, Armando E , McCall, Linda , Beitsch, Peter ... - - Ann Surg - 2010

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011

Accuracy of FDG-PET within the clinical practice of the ACOSOG Z4031 trial to diagnose clinical stage I NSCLC

Grogan, Eric L. , Deppen, Stephen A. , Ballman, Karla V. ... - - Ann Thorac Surg - 2014

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4031

Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)

Haddad, Tufia C. , He, Jun , O'Sullivan, Ciara C. , Chen, Beiyun ... - - Breast Cancer Res Treat - 2021

Manuscript - Primary - Primary - Breast - N0733

Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial

Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - - Int J Radiat Oncol Biol Phys - 2019

Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Radiation use and field design in women with node positive breast cancer treated with preoperative systemic therapy and breast surgery including axillary dissection on a prospective clinical trial ACOSOG Z1071 [Alliance]

Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - ASTRO - Int J Radiation Biol Physics - 2015

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: Results from ACOSOG Z1071 (Alliance)

Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - - Int J Radiat Oncol Biol Phys - 2016

Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy (NAC) and axillary lymph node dissection (ALND); results from ACOSOG Z1071 (Alliance)

Haffty, Bruce , Ballman, Karla , Hunt, Kelly , McCall, Linda ... - ASTRO - Int J Radiat Oncol Biol Phys - 2016

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).

Haluska, Paul , Bernath, Albert M. , Ballman, Karla V. ... - ASCO - J Clin Oncol - 2014

Abstract - Primary - Primary - Breast - N0733

Local control after resection and adjuvant radiosurgery compared to radiosurgery alone for brain metastasis: Exploratory analysis of Alliance NCCTG N107C

Hansen, Chase C. , Ballman, Karla V. , Anderson, S. Keith ... - ASTRO - Int J Radiation Biol Physics - 2020

Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C

Factors Associated with Local-Regional Recurrence Following a Negative Sentinel Node Dissection: Results of the ACOSOG Z0010 Trial

Hunt, Kelly K. , Ballman, Karla V. , McCall, Linda M. ... - - Ann Surg - 2012

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010

Association of Circulating Markers with Cognitive Decline After Radiation Therapy for Brain Metastasis.

Huntoon, Kristin , Anderson, S Keith , Ballman, Karla V , Twohy, Erin ... - - Neuro Oncol - 2022

Manuscript - Secondary - Primary - Correl Sci NOS - A152023 , N107C

Functional Decline and Resilience among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Hurria, Arti , Soto-Perez-de-Celis, Enrique , Allred, Jacob B. ... - - J Am Geriatr Soc - 2019

Manuscript - Secondary - Primary - Older Adult - CALGB-361007 , CALGB-49907

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for those Patients whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations (Alliance A031701)

Iyer, Gopa , Ballman, Karla V. , Atherton, Pamela , Murray, Katie ... - ASCO - J Clin Oncol - 2022

Abstract - No-Endpoint - Trial-Description-Only - GU - A031701

Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance)

Iyer, Gopa , Halabi, Susan , Luo, Bin , Choi, Woonyoung ... - ASCO - J Clin Oncol - 2022

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90601

CODEL: Phase III study of RT alone, RT plus temozolomide, or temozolomide alone for newly diagnosed 1P/19Q codeleted anaplastic oligodendroglioma patients. Updated analysis from the initial study design (NCCTG N0577, Alliance)

Jaeckle, Kurt A. , Ballman, Karla V. , van den Bent, Martin ... - SNO - Neuro-oncology - 2020

Abstract - Primary - Other - Neuro-Onc - N0577

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma

Jaeckle, Kurt A. , Ballman, Karla , Furth, Alfred ... - - Neurology - 2009

Manuscript - Primary - Primary - Neuro-Onc - N0475

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Jaeckle, Kurt A , Ballman, Karla V , van den Bent, Martin ... - - Neuro Oncol - 2020

Manuscript - Primary - Preliminary - Neuro-Onc - N0577

CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III randomized study of RT vs. RT+TMZ vs. TMZ for newly diagnosed 1p/19q-codeleted anaplastic glioma. Analysis of patients treated on the original protocol design

Jaeckle, Kurt , Vogelbaum, Michael , Ballman, Karla ... - AAN - Neurology - 2016

Abstract - Primary - Other - Neuro-Onc - N0577

CODEL (Alliance N0577; EORTC 26081/22086 ; NRG 1071; NCIC CEC-2): A Phase III Randomized Intergroup Study for patients (pts) with newly diagnosed 1p/19q codeleted anaplastic glioma. Preliminary analysis of patients treated on the original protocol design with RT vs. RT + concomitant/adjuvant TMZ vs. TMZ alone

Jaeckle, Kurt , Voglebaum, Michael , Ballman, Karla ... - SNO - Neuro Oncol - 2015

Abstract - Primary - Preliminary - Neuro-Onc - N0577

Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

Jagsi, Reshma , Chadha, Manjeet , Moni, Janaki , Ballman, Karla ... - - J Clin Oncol - 2014

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011

Social Support and Its Implications in Older, Early-Stage Breast Cancer Patients in CALGB 49907 (Alliance A171301)

Jatoi, Aminah , Muss, Hyman , Allred, Jake B. , Cohen, Harvey J. ... - - Psycho-Oncol - 2016

Manuscript - Secondary - Primary - Older Adult - A171301 , CALGB-49907

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Joensuu, Heikki , Eriksson, Mikael , Hall, Kirsten Sundby ... - - Cancer - 2014

Manuscript - Secondary-not-in-original - Primary - GI - ACOSOG-Z9001

Nomogram-Based Estimate of Axillary Nodal Involvement in ACOSOG Z0011 (Alliance): Validation and Association with Radiation Protocol Variations and Outcomes

Katz, Matthew S. , McCall, Linda , Ballman, Karla , Haffty, Bruce G. ... - ASTRO - Int J Radiat Oncol Biol Phys - 2018

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z0011

Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations

Katz, Matthew S. , McCall, Linda , Ballman, Karla , Jagsi, Reshma ... - - Breast Cancer Res Treat - 2020

Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z0011

Using ePrognosis to Estimate 2-year All-Cause Mortality in Older Women with Breast Cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)

Kimmick, Gretchen G , Major, Brittny , Clapp, Jonathan , Sloan, Jeff ... - - Breast Cancer Res Treat - 2017

Manuscript - Primary - Primary - Older Adult - A151503 , CALGB-369901 , CALGB-49907

Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)

Klepin, Heidi D. , Pitcher, Brandelyn N. , Ballman, Karla V. ... - - J Oncol Pract - 2014

Manuscript - Secondary - Primary - Older Adult - CALGB-361004 , CALGB-49907

Feasibility of geriatric assessment for older adults with acute myeloid leukemia (AML) receiving intensive chemotherapy on a cooperative group trial: CALGB 361006 (Alliance).

Klepin, Heidi D. , Ritchie, Ellen K. , Sanford, Ben L. ... - ASCO - J Clin Oncol - 2014

Abstract - Primary - Primary - Older Adult - CALGB-361006

Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).

Klepin, Heidi D , Ritchie, Ellen , Major-Elechi, Brittny ... - - J Geriatr Oncol - 2020

Manuscript - Primary - Primary - Older Adult - CALGB-361006

Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain

Knutson, Keith L. , Clynes, Raphael , Shreeder, Barath ... - - Cancer Res - 2016

Manuscript - Secondary-not-in-original - Meta-Analysis - Breast - N0337 , N98-32-52 , N0938

Associations of HER2-Specific Immunity with Survival During Treatment with Trastuzumab and Chemotherapy in Breast Cancer

Knutson, Keith L. , Clynes, Raphael , Yeramian, Patrick ... - ASCO - J Clin Oncol - 2015

Abstract - Secondary-not-in-original - Meta-Analysis - Breast - N0337 , N98-32-52 , N0938

CHOD/BVAM Chemotherapy and Whole-Brain Radiotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma

Laack, Nadia N. , O'Neill, Brian Patrick , Ballman, Karla V. ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Primary - Primary - Lymphoma - NCCTG-93-73-51

Central review versus local review of axillary ultrasound prior to and after neoadjuvant chemotherapy: Results from the American College of Surgeons Oncology Group Z1071 trial (Alliance)

Le-Petross, H. Carisa , McCall, Linda M. , Hunt, Kelly K. ... - ARRS - - 2019

Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071

Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)

Le-Petross, Huong T. , McCall, Linda M. , Hunt, Kelly K. ... - - AJR Am J Roentgenol - 2018

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Identifying Risk Factors For Toxicity In Patients With Hormone-Receptor Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study

Li, Daneng , Dickler, Maura N. , McCall, Linda M. , Hahn, Olwen M ... - ASCO - J Clin Oncol - 2016

Abstract - Secondary - Primary - Older Adult - CALGB-40503

Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: A CALGB 40503 (Alliance) correlative study.

Li, Daneng , McCall, Linda M. , Hahn, Olwen M , Hudis, Clifford A. ... - - Breast Cancer Res Treat - 2018

Manuscript - Secondary - Primary - Older Adult - CALGB-40503

Role of age, BMI, and tumor subtype in racial/ethnic disparities in breast cancer survival: A pooled analysis of four Alliance adjuvant clinical trials.

Lipsyc-Sharf, Marla , Ballman, Karla V. , Campbell, Jordan D. ... - AACR - Cancer Res - 2022

Abstract - Secondary-not-in-original - Meta-Analysis - Breast - CALGB-40101 , CALGB-49907 , CALGB-9741 , NCCTG-N9831

Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients

Locke, Dona E.C. , Decker, Paul A. , Sloan, Jeff A. , Brown, Paul D. ... - - J Pain Symptom Manage - 2007

Manuscript - Secondary-not-in-original - Comprehensive - Neuro-Onc - N0074 , NCCTG-98-72-51 , NCCTG-98-72-52

Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab

Magbanua, Mark Jesus M. , Savenkov, Oleksandr , Asmus, Erik J. ... - - Clin Cancer Res - 2020

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-40503

Clinical significance of circulating tumor cells (CTCs) in hormone receptor-positive (HR+) metastatic breast cancer (MBC) patients receiving letrozole or letrozole plus bevacizumab: CALGB 40503 (Alliance)

Magbanua, Mark Jesus M. , Savenkov, Oleksandr , Asmus, Erik J. ... - ASCO - J Clin Oncol - 2019

Abstract - Secondary - Primary - Breast - CALGB-40503

Association between molecular subtype membership or hypoxia-associated gene expression signatures and clinical outcomes in the CALGB 90601 (Alliance) Phase 3 clinical trial of Gemcitabine and Cisplatin (GC) plus bevacizumab (B) or placebo (P)

McConkey, David J , Choi, Woonyoung , Halabi, Susan , Luo, Bin ... - ASCO - J Clin Oncol - 2022

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90601

Measurement of endocrine activity (SET2,3) related to prognosis and prediction of benefit from dose-dense chemotherapy in estrogen receptor-positive (ER+) cancer: correlative analysis of C9741 (Alliance).

Metzger, Otto , Ballman, Karla , Campbell, Jordan , Liu, Minetta ... - ASCO - J Clin Oncol - 2022

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-9741

The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.

Meyers, Bryan F , Downey, Robert J , Decker, Paul A ... - - J Thorac Cardiovasc Surg - 2007

Manuscript - Primary - Primary - Respiratory - ACOSOG-Z0060

Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer

Mittendorf, Elizabeth A. , Ballman, Karla V. , McCall, Linda M. ... - - J Clin Oncol - 2015

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010

Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831

Norton, Nadine , Olson, Rebecca M. , Pegram, Mark , Tenner, Kathleen ... - - Cancer Immunol Res - 2014

Manuscript - Secondary - Primary - Breast - N9831

Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer (NCT04457596)

O'Sullivan, Ciara C. , Ballman, Karla V. , McCall, Linda ... - ASCO - J Clin Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - Breast - A011801

Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer

O'Sullivan, Ciara C , Ballman, Karla V , McCall, Linda ... - - Future Oncol - 2021

Manuscript - No-Endpoint - Trial-Description-Only - Breast - A011801

Survival implications of variation in the thoroughness of pathologic lymph node examination in American College of Surgeons Oncology Group Z0030 (Alliance)

Osarogiagbon, Raymond U. , Decker, Paul A. , Ballman, Karla ... - - Ann Thorac Surg - 2016

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Survival implications of variation in the lymph node (LN) count in ACOSOG Z0030 (Alliance)

Osarogiagbon, Raymond U. , Decker, Paul , Ballman, Karla ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis

Palmer, Joshua D. , Klamer, Brett G. , Ballman, Karla V. ... - - JAMA Oncol - 2022

Manuscript - Secondary-not-in-original - Primary - Neuro-Onc - N107C

Effect of stereotactic radiosurgery compared to whole-brain radiotherapy for limited brain metastasis on long term cognition and quality of life: A pooled analysis of N107C/CEC.3 and N0574 randomized clinical trials (Alliance)

Palmer, Joshua D. , Klamer, Brett G. , Ballman, Karla V. ... - ASTRO - Int J Radiation Biol Physics - 2020

Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcomes - N0574 , N107C

Analysis of the associations of FC gamma receptor polymorphisms (FCGR3A, FCGR2A, and FCGR2B) with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) trial N9831

Pegram, Mark , Norton, Nadine , Tenner, Kathleen , Ballman, Karla L. ... - AACR Adv Br - Mol Cancer Res - 2013

Abstract - Secondary-not-in-original - Primary - Breast - N9831

The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831

Perez, Edith A. , Baehner, Frederick L. , Butler, Steven M. ... - - Breast Cancer Res - 2015

Manuscript - Secondary - Primary - Breast - NCCTG-N9831

Stromal tumor infiltrating lymphocytes: In the Alliance N9831 trial STILS are prognostic of chemotherapy benefit but not predictive of trastuzumab benefit

Perez, Edith A. , Ballman, Karla V. , Anderson, S. Keith ... - SABCS - Cancer Res - 2015

Abstract - Secondary-not-in-original - Primary - Breast - N9831

Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial

Perez, Edith A. , Ballman, Karla V. , Mashadi-Hossein, Afshin ... - - J Natl Cancer Inst - 2016

Manuscript - Secondary - Primary - Breast - N9831

Intrinsic subtype and therapeutic response among early stage HER2-positive breast tumors from the North Central Cancer Treatment Group (Alliance) N9831 trial

Perez, Edith A. , Ballman, Karla V. , Mashadi-Hossein, Afshin ... - SABCS - Cancer Res - 2016

Abstract - Secondary - Primary - Breast - N9831

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

Perez, Edith A. , Ballman, Karla V. , Tenner, Kathy S. ... - - JAMA Oncol - 2016

Manuscript - Secondary - Primary - Breast - N9831

Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.

Perez, Edith A. , Thompson, E. Aubrey , Anderson, S. Keith ... - ASCO - J Clin Oncol - 2014

Abstract - Secondary-not-in-original - Primary - Breast - N9831

Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Perez, Edith A. , Thompson, E. Aubrey , Ballman, Karla V. ... - - J Clin Oncol - 2015

Manuscript - Secondary - Primary - Breast - N9831

IGF1R Protein Expression is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2-positive Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831

Reinholz, Monica M. , Chen, Beiyun , Dueck, Amylou C. ... - - Clin Cancer Res - 2017

Manuscript - Secondary - Primary - Breast - NCCTG-N9831

N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group): Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease: Cognitive function of long-term survivors

Roberge, David , Ballman, Karla V. , Cerhan, Jane H. ... - SNO - Neuro-oncology - 2017

Abstract - Secondary - Primary - Neuro-Onc - N107C

Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)

Rosenberg, Jonathan E. , Ballman, Karla A. , Halabi, Susan ... - - J Clin Oncol - 2021

Manuscript - Primary - Primary - GU - CALGB-90601

CALGB 90601 (Alliance): Randomized, double blind, placebo-controlled phase III trial comparing gemcitabine and cisplatin with bevacizumab or placebo in patients with metastatic urothelial carcinoma

Rosenberg, Jonathan , Ballman, Karla , Halabi, Susan , Watt, Colleen ... - ASCO - J Clin Oncol - 2019

Abstract - Primary - Primary - GU - CALGB-90601

Cosmetic outcome following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study

Rosenkranz, Kari M. , Ballman, Karla V. , McCall, Linda ... - ASBrS - Ann Surg Oncol - 2020

Abstract - Secondary - Primary - Breast - Z11102

The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) trial

Rosenkranz, Kari M. , Ballman, Karla , McCall, Linda ... - - Ann Surg Oncol - 2018

Manuscript - Secondary - Preliminary - Breast - Z11102

Cosmetic outcomes following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study

Rosenkranz, Kari M. , Ballman, Karla , McCall, Linda ... - - Ann Surg Oncol - 2020

Manuscript - Secondary - Primary - Breast - Z11102

The feasibility of breast conserving surgery for multiple ipsilateral breast cancer: an initial report from ACOSOG Z11102 (Alliance) trial

Rosenkranz, Kari , McCall, Linda , Ballman, Karla ... - ASBrS - Ann Surg Oncol - 2018

Abstract - Secondary - Primary - Breast - Z11102

Randomized Phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) with MGMT promoter hypermethylation

Sarkaria, Jann N. , Ballman, Karla V. , Kizilbash, Sani H. ... - ASCO - J Clin Oncol - 2022

Abstract - Primary - Primary - Neuro-Onc - A071102

Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01)

Schumacher, Jessica R , Neuman, Heather B , Yu, Menggang ... - - J Natl Cancer Inst - 2022

Manuscript - Primary - Primary - CCDR - AFT-01

Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact.

Shah, Mithun Vinod , Wiktor, Anne E. , Meyer, Reid G. ... - ASCO - J Clin Oncol - 2014

Abstract - Secondary-not-in-original - Primary - Breast - N9831

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

Shepherd, Jonathan H. , Ballman, Karla , Polley, Mei-Yin C. ... - - J Clin Oncol - 2022

Manuscript - Primary - Long-Term-Followup - Breast - CALGB-40603

Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study

Shi, Qian , You, Y Nancy , Nelson, Heidi , Allen, Mark S ... - - Clin Trials - 2010

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030

A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072

Simmons, Rache M. , Ballman, Karla V. , Cox, Charles , Carp, Ned ... - - Ann Surg Oncol - 2016

Manuscript - Primary - Primary - Breast - ACOSOG-Z1072

A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results From ACOSOG (Alliance) Z1072

Simmons, Rache , Ballman, Karla , Cox, Charles , Carp, Ned ... - ASBrS - Ann Surg Oncol - 2014

Abstract - Primary - Primary - Breast - ACOSOG-Z1072

Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (Alliance)

Trifiletti, Daniel M. , Ballman, Karla V. , Brown, Paul D. ... - ASTRO - International Journal of Radiation Oncology • Biology • Physics - 2019

Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C

Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).

Trifiletti, Daniel M , Ballman, Karla V , Brown, Paul D ... - - Int J Radiat Oncol Biol Phys - 2020

Manuscript - Secondary-not-in-original - Primary - Neuro-Onc - N107C

Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group study N0074 1

Uhm, Joon H. , Ballman, Karla V. , Wu, Wenting , Giannini, Caterina ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Primary - Primary - Neuro-Onc - N0074

Impact of Race, Ethnicity and BMI on Achievement of Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer: A Pooled Analysis of Four Prospective Alliance Clinical Trials (A151426)

Warner, Erica T. , Ballman, Karla V. , Strand, Carrie , Boughey, Judy ... - - Breast Cancer Res Treat - 2016

Manuscript - Primary - Primary - Disparities - A151426 , ACOSOG-Z1041 , ACOSOG-Z1071 , CALGB-40601 , CALGB-40603

Age, Race, BMI and Pathologic Complete Response Following Neoadjuvant Chemotherapy: An Analysis of Four Alliance Clinical Trials

Warner, Erica T. , Ballman, Karla V. , Strand, Carrie ... - ASCO Breast - J Clin Oncol - 2015

Abstract - Primary - Primary - Disparities - A151426 , ACOSOG-Z1031 , ACOSOG-Z1041 , CALGB-40601 , CALGB-40603

Factors associated with nodal pathologic complete response among breast cancer patients treated with neoadjuvant chemotherapy: results of CALGB 40601 (HER2+) and 40603 (triple-negative) (Alliance)

Weiss, Anna , Campbell, Jordan , Ballman, Karla V. ... - - Ann Surg Oncol - 2021

Manuscript - Secondary-not-in-original - Primary - Breast - CALGB-40601 , CALGB-40603

Factors associated with residual nodal disease among breast cancer patients treated with neoadjuvant chemotherapy: Results of CALGB 40601 (HER2-positive) and 40603 (triple negative) (Alliance)

Weiss, Anna , Campbell, Jordan , Ballman, Karla , Sikov, William ... - SSO - Ann Surg Oncol - 2021

Abstract - Secondary-not-in-original - Primary - Breast - CALGB-40601 , CALGB-40603

Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010

Wilke, Lee G. , Ballman, Karla V. , McCall, Linda M. ... - - Ann Surg Oncol - 2010

Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z0010

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO GU - J Clin Oncol - 2021

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - IKCS - J Clin Oncol - 2020

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2019

Abstract - No-Endpoint - Trial-Description-Only - GU - A031704

A Pooled Analysis of the Cardiac Events in the Trastuzumab Adjuvant Trials

de Azambuja, Evandro , Ponde, Noam , Procter, Marion , Rastogi, Priya ... - - Breast Cancer Res Treat - 2020

Manuscript - Secondary-not-in-original - Primary - Breast - NCCTG-N9831